CTCs in blood samples from 107 BC patients were evaluated using immunomagnetic depletion and multi‐marker immunofluorescence (EpCAM, E‐cadherin, MCAM, cell surface vimentin, CD31, CD45), followed by single‐cell transcriptomics. The gene discussed is PECAM1; the disease is breast cancer.